4-(4-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-5-yl)benzyl)thiomorpholine 1,1-dioxide
|
1257705-09-1
|
1257705-09-1
|
3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]isothiazole
|
|
|
4-(2-(3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)ethyl)morpholine
|
|
1426671-36-4
|
2-(2,2,2-trifluoroacetyl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonyl chloride
|
2-(2,2,2-三氟乙酰基)-1,2,3,4-四氢异喹啉-6-磺酰氯
|
169949-39-7
|
2-[4-(4-Chlorophenoxy)phenoxy]propionic acid
|
2-(4-(4-氯苯氧基)苯氧基)丙酸
|
26129-32-8
|
2,6-DIMETHYL-4'-(TRIFLUOROMETHYL)-[1,1'-BIPHENYL]-4-OL
|
2,6-二甲基-4-(三氟甲基)-[1,1-联苯]-4-醇
|
872258-58-7
|
1H-Indazole-3,5-dicarboxylic acid 5-methyl ester
|
1H-Indazole-3,5-dicarboxylic acid 5-methyl ester
|
797804-53-6
|
1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride
|
1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐
|
25952-53-8
|
UNC669
|
5-溴烟酸
|
20826-04-4
|
UNC-1215
|
UNC1215
|
1415800-43-9
|
CC-90010
|
CC-90010
|
1706738-98-8
|
WQ1 1204401-49-9
|
化合物Σ1 RECEPTOR ANTAGONIST-1
|
1204401-49-9
|
Ulixacaltamide (Z944)
|
N-((1-(2-(叔丁基氨基)-2-氧代乙基)哌啶-4-基)甲基)-3-氯-5-氟苯甲酰胺
|
1199236-64-0
|
H3B-120
|
H3B-120
|
2194903-42-7
|
BCI-121
|
BCI-121
|
432529-82-3
|
FGTI-2734
|
FGTI-2734
|
1247018-19-4
|
Dacinostat
|
达诺司他
|
404951-53-7
|
AZ960
|
5-氟-2-[[(1S)-1-(4-氟苯基)乙基]氨基]-6-[(5-甲基-1H-吡唑-3-基)氨基]-3-吡啶腈
|
905586-69-8
|
STF-62247
|
N-(3-甲基苯基)-4-(4-吡啶)-2-噻唑胺
|
315702-99-9
|
NVP-BVU 972
|
6-[[6-(1-甲基-1H-吡唑-4-基)咪唑并[1,2-B]哒嗪-3-基]甲基]喹啉
|
1185763-69-2
|
SR10067
|
[3-[[4-(1,1-Dimethylethoxy)phenoxy]methyl]-3,4-dihydro-2(1H)-isoquinolinyl]-1-naphthalenylmethanone
|
1380548-02-6
|
LP-935509
|
化合物LP-935509
|
1454555-29-3
|
KHS101 hydrochloride
|
盐酸KHS101
|
1784282-12-7
|
PIK-93
|
N-[5-[4-氯-3-[[(2-羟基乙基)氨基]磺酰基]苯基]-4-甲基-2-噻唑基]乙酰胺
|
593960-11-3
|
OgleMilast
|
N-(3,5-二氯吡啶-4-基)-4-二氟甲氧基-8-[(甲磺酰基)氨基]二苯并[B,D]呋喃-1-甲酰胺
|
778576-62-8
|
SYP-5
|
1384268-04-5
|
1384268-04-5
|
Lofepramine
|
洛非帕明
|
23047-25-8
|
WS6
|
WS6
|
1421227-53-3
|
JC124
|
Benzamide, 5-chloro-2-methoxy-N-[2-[4-[(methylamino)sulfonyl]phenyl]ethyl]-
|
1638611-48-9
|
SB 657510
|
2-溴-N-[4-氯-3-[[(3R)-1-甲基-3-吡咯烷基]氧基]苯基]-4,5-二甲氧基-苯磺酰胺
|
474960-44-6
|
NTNCB hydrochloride
|
2-硝基-N-[[反式-4-[[(1,2,3,4-四氢-2-萘基)甲基]氨基]甲基]环己基]甲基]苯磺酰胺盐酸盐
|
191931-56-3
|
RU-TRAAK-2
|
化合物RU-TRAAK-2
|
1210538-56-9
|
TR-14035
|
(ALPHAS)-ALPHA-[(2,6-二氯苯甲酰)氨基]-2',6'-二甲氧基联苯-4-丙酸
|
232271-19-1
|
YUM08164
|
1H-Pyrazole-3-carboxamide, N-(cyanomethyl)-4,5-dihydro-1,5-diphenyl-
|
1333608-16-4
|
NSC 625987
|
NSC 625987
|
141992-47-4
|
ZX-29
|
ZX-29
|
2254805-62-2
|
VU-0155069
|
CAY10593
|
1130067-06-9
|
TL02-59
|
3-(6,7-dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide
|
1315330-17-6
|
FABPs ligand 6
|
化合物 FABPS LIGAND 6
|
|
GSK329
|
化合物 T24109
|
1268490-12-5
|
WAY-111543
|
WAY-111543
|
868269-74-3
|
A-381393
|
A-381393
|
726174-00-1
|
MELK-8a hydrochloride
|
MELK8A HYDROCHLORIDE
|
2096992-20-8
|
TBK1/IKKε-IN-5
|
Benzonitrile, 5-[4-[[4-[4-(3-oxetanyl)-1-piperazinyl]phenyl]amino]-1,3,5-triazin-2-yl]-2-[(tetrahydro-2H-pyran-4-yl)oxy]-
|
1893397-65-3
|
GPR40
|
GPR40/FFAR1 modulator 1
|
874755-26-7
|
JH-X-119-01
|
2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)-
|
2227368-54-7
|
BX 513 hydrochloride
|
BX 513盐酸盐
|
1216540-18-9
|
Halopemide
|
卤培米特
|
59831-65-1
|
CL-349010
|
CL-349010
|
868269-33-4
|
NMS-E973
|
NMS-E973
|
1253584-84-7
|
Timapiprant sodium
|
TIMAPIPRANT SODIUM
|
950688-14-9
|
M4205
|
化合物M4205
|
2590556-80-0
|
TAK-901
|
5-[3-(乙基磺酰基)苯基]-3,8-二甲基-N-(1-甲基-4-哌啶基)-9H-吡啶并[2,3-B]吲哚-7-甲酰胺
|
934541-31-8
|
SR-2211
|
2-Fluoro-4'-[[4-(4-pyridinylMethyl)-1-piperazinyl]Methyl]-伪,伪-bis(trifluoroMethyl)-[1,1'-biphenyl]-4-Methanol
|
1359164-11-6
|
IWP-L6
|
IWP-L6
|
1427782-89-5
|
CCR6 inhibitor 1
|
2-Pyridinecarboxamide, 4-[4-[[trans-4-[[5-(trifluoromethyl)-2-pyridinyl]amino]cyclohexyl]sulfonyl]phenyl]-
|
2437547-04-9
|
Perospirone
|
哌罗匹隆
|
150915-41-6
|
Teijin compound 1
|
化合物 T19230
|
1313730-14-1
|
Mebeverine Acid
|
美贝维林 盐酸盐
|
475203-77-1
|
Sulfatinib
|
5-羟基-2-甲基吲哚
|
1308672-74-3
|
NVP-BHG712
|
4-甲基-3-[[1-甲基-6-(3-吡啶基)-1H-吡唑并[3,4-D]嘧啶-4-基]氨基]-N-[3-(三氟甲基)苯基]苯甲酰胺
|
940310-85-0
|
UNC0379
|
UNC0379
|
1620401-82-2
|
ZINC00881524
|
557782-81-7
|
557782-81-7
|
3,4-dimethoxy-N-[4-(3-nitrophenyl)-1,3-thiazol-2-yl]benzenesulfonamide
|
RO 61-8048
|
199666-03-0
|
PDS-0330
|
|
2904682-19-3
|
Ninerafaxstat 3HCl
|
化合物NINERAFAXSTAT TRIHYDROCHLORIDE
|
2311824-72-1
|
CXCR7 antagonist-1
|
|
1613021-99-0
|
Dovramilast
|
化合物 DOVRAMILAST
|
340019-69-4
|
Sivelestat (ONO5046, LY544349, EI546)
|
西维来司他
|
127373-66-4
|
Toceranib
|
Toceranib
|
356068-94-5
|
4-[(2-(2-Aminoethoxy)ethyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl
|
泊马度胺 4'-PEG1-胺
|
2154342-56-8
|
Mibampator(LY451395)
|
MIBAMPATOR
|
375345-95-2
|
Bevenopran
|
676500-67-7
|
676500-67-7
|
Benzamide, 4-butoxy-N-[[4-(dimethylamino)tetrahydro-2H-pyran-4-yl]methyl]-3,5-dimethoxy-, hydrochloride (1:1)
|
Opiranserin盐酸盐
|
1440796-75-7
|
GSK854
|
3-((6-((5-chloropyridin-2-yl)amino)pyrimidin-4-yl)amino)-4-(ethylsulfonyl)-N-methylbenzenesulfonamide
|
1316059-00-3
|
SR18662
|
(E)-3-(3,4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide
|
2505001-62-5
|
SR15006
|
SR 15006
|
2505001-54-5
|
DUN61488
|
ONC212
|
1807861-48-8
|
Tigulixostat
|
化合物 TIGULIXOSTAT
|
1287766-55-5
|
A-443654
|
(ALPHAS)-ALPHA-[[[5-(3-甲基-1H-吲唑-5-基)-3-吡啶基]氧基]甲基]-(S)-1H-吲哚-3-乙胺
|
552325-16-3
|
PHT-427
|
4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺
|
1191951-57-1
|
GNE-9815
|
化合物GNE-9815
|
2729996-45-4
|
DY 268
|
DY 268
|
1609564-75-1
|
ATC 0175 hydrochloride
|
ATC 0175
|
510733-97-8
|
Teijin Compound 1 HCl
|
|
313730-14-1
|
Ezatiostat
|
EZATIOSTAT游离的
|
168682-53-9
|
BMS-833923
|
BMS-833923
|
1059734-66-5
|
LDN-193189 (DM3189) 2HCl
|
LDN-193189 2HCL
|
1435934-00-1
|
V-9302
|
V-9302
|
1855871-76-9
|
31816-70-3
|
4-[(1,5-二甲基-3-氧代-2-苯基-2,3-二氢-1H-吡唑-4-基)氨磺酰基]苯甲酸
|
31816-70-3
|
Grp94inhibitor-1
|
GRP94
|
2234897-35-7
|
Laquinimod
|
拉喹莫德
|
248281-84-7
|
Tasquinimod
|
他喹莫德
|
254964-60-8
|
FIPI
|
FIPI
|
939055-18-2
|
SB 218795
|
化合物 T23316
|
174635-53-1
|
FL-411
|
2-(4-羟基-3,5-二甲基苯基)-7-甲基-5,6,7,8-四氢吡啶并[4',3':4,5]噻吩并[2,3-D]嘧啶-4(1H)-酮
|
2118944-88-8
|
LMI070
|
化合物LMI 070
|
1562338-42-4
|
YKL 06-061
|
YKL 06-061
|
2172617-15-9
|
NEO2734 (EP31670)
|
化合物NEO2734
|
2081072-29-7
|
PLX51107
|
化合物PLX51107
|
1627929-55-8
|